Mb, Levis & Associates, LLC Dexcom Inc Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 32 shares of DXCM stock, worth $2,568. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 32
-0.0%
Holding current value
$2,568
Previous $2.49 Million
12.21%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,080Shares Held
359MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.73 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.34 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.15 Billion0.24% of portfolio
-
Baillie Gifford & CO14.2MShares$1.14 Billion0.87% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...